drugset / Trial / NCT01216371
Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)
Phase 2
Unknown
60 enrolled
Association of Urologic Oncology (AUO)
University Hospital, Essen · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim ist to identify biomarkers in the blood, to indicate early response or early treatment resistance.
Timeline
- Start
- 2010-10
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sunitinib | Small molecule | 50 mg | — |